Abbott Diet Pill to Face Tougher Warnings from European Drug Agency


Abbott Diet Pill to Face Tougher Warnings from European Drug Agency

European regulatory authorities on Thursday said an Abbott Laboratories (ABT) diet pill should be banned from sale in the market, issuing tougher warnings for the drug because the drug poses high risks of stroke and heart attack.

The warning was conveyed after a study of 10,000 patients suggested it put them at a higher risk for heart disease.

The study revealed 11.4% of those who used Meridia as a medication faced a cardiovascular event such as a heart attack, compared with 10% of patients who received a fake pill.

This medicine is sold in Europe under the brand-names Reductil, Reduxade, Zelium and other names; and as Meridia in the U. S.

The warning for not to use Meridia is to include patients with a history of problems as Coronary artery disease, heart attack, transient ischemic attack, Arrhythmia, Congestive heart failure, Peripheral arterial disease, uncontrolled hypertension.

The agency's decision will now get passed to the European Commission for review.

The FDA said Abbott has agreed to update the label bearing “recommended the drug shouldn't be used in patients with a history of heart disease, “and further plans to convene an advisory committee meeting to further discuss the safety and risks with Meridia.

Latest News

United’s New CEO Oscar Muñoz Aims at Improving relation with Workers
The September Job Number Hint at a Sluggish Patch
First Data Launches its IPO, Targets to Raise Up to $3.7 Billion
ConAgra’s Head Quarter Move Announcement gets Positive but ‘Muted’
Dunkin’ Donut Franchisee Plans to Close One Hundred Stores
Mr. Munoz New CEO of United Airline says Things will Improve under his Leadershi
Reportedly Walmart is Planning to Trim Hundreds of Jobs at its Bentonville
The Government Looking Deeper into Safety Issues; Transportation Secretary
Data Shows Rise in Local Home Prices Slow Down but Surpass the U.S. Average
Oil Futures Drop as U.S. Inventories Show Build-up Surpassing Analysts
Gap’s, Old Navy Head, to Become the new CEO of Ralph Lauren Corp.
Majority of UAW Workers at Warren Truck and Mack Engine Plant Vote in Favor